13 research outputs found
Hypertension evaluated in the public and private Brazilian health system hypertension in public and private service
IntroductionHypertension (HT) remains the leading cause of death worldwide. In Brazil it is estimated that 35% of the adult population has HT and that about 20% of these have blood pressure values within the targets recommended for the reduction of cardiovascular risk. There are some data that point to different control rates in patients treated by cardiologists in public and private referral center and this is an important point to be investigated and discussed.ObjectiveTo compare sociodemographic characteristics, body mass index (BMI), antihypertensive (AH) drugs, blood pressure (BP) and control rate in public (PURC) and private (PRRC) referral centers.MethodologyA cross-sectional multicenter study that analyzed data from hypertensive patients assisted by the PURC (one in Midwest Region and other in Northeast region) and PRRC (same distribution). Variables analyzed: sex, age, BMI, classes, number of AH used and mean values of systolic and diastolic BP by office measurement and home blood pressure measurement (HBPM). Uncontrolled hypertension (HT) phenotypes and BP control rates were assessed. Descriptive statistics and χ2 tests or unpaired t-tests were performed. A significance level of p < 0.05 was considered.ResultsA predominantly female (58.9%) sample of 2.956 patients and a higher prevalence of obesity in PURC (p < 0.001) and overweight in PRRC (p < 0.001). The mean AH used was 2.9 ± 1.5 for PURC and 1.4 ± 0.7 for PRRC (p < 0.001). Mean systolic and diastolic BP values were higher in PURC as were rates of uncontrolled HT of 67.8% and 47.6% (p < 0.001) by office measurement and 60.4% and 35.3% (p < 0.001) by HBPM in PURC and PRRC, respectively.ConclusionPatients with HT had a higher prevalence of obesity in the PURC and used almost twice as many AH drugs. BP control rates are worse in the PURC, on average 15.3 mmHg and 12.1 mmHg higher than in the PRRC by office measurement
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension
Aims
Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries.
Methods and results
Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension.
Conclusion
May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk
How should treated hypertensive patients with systolic blood pressure below 120 mmHg be managed?
sem informação402520892090CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ306154/2017-
Ambulatory blood pressure phenotypes and isolated elevation of office central or brachial blood pressure
Ambulatory blood pressure phenotypes and isolated elevation of office central or brachial blood pressure
Disagreements in office brachial and central blood pressure (BP) have resulted in the identification of novel hypertension phenotypes, namely isolated central hypertension (ICH) and isolated brachial hypertension (IBH). This study investigated the relationship of ICH and IBH with ambulatory BP phenotypes among 753 individuals (mean age = 47.6 ± 15.2 years, 48% males) who underwent office and 24‐hours brachial and central BP measures using a Mobil‐O‐Graph PWA monitor. Thresholds for elevated office central and brachial BP were 130/90 and 140/90 mm Hg. Results of multivariable analysis adjusted for potential confounders showed that ICH (n = 25) had 3.71‐fold (95% CI 1.48‐9.32; P = .005) greater risk of masked hypertension than normal brachial/central BP (n = 362), while IBH (n = 20) had 4.65‐fold (95% CI 1.76‐12.25; P = .002) greater risk of white coat hypertension compared with combined brachial/central hypertension (n = 346). These findings suggest that the diagnosis of ICH and IBH might be useful in identifying individuals at higher risk of presenting discordant office and ambulatory BP phenotypes22101936194
Correlation between office and 24-hour ambulatory measures of pulse wave velocity, central augmentation index and central blood pressure
Sem informação21233533
Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring
The values used to define the presence of white-coat or masked blood pressure (BP) effects are arbitrary. The aim of this study was to investigate the accuracy of several cutoff points based on the difference between office and home BP (.BP) values to detect white-coat uncontrolled (WUCH) and masked uncontrolled (MUCH) hypertension, which are phenotypes with adverse prognoses, in a large cohort of treated hypertensive patients. This multicenter cross-sectional study included 6,049 treated hypertensive patients (40% males, mean age 59.1 +/- 14.4 years) who underwent office and home BP monitoring. We compared the sensitivity, specificity, area under curve (AUC), and positive (PPV) and negative (NPV) predictive values of several.BP cutoffs to detect WUCH and MUCH. The 15/9 mmHg cutoff, which reflects a 1.0 standard deviation of the.BP, showed the best AUC (0.783, 95% CI = 0.772-0.794) for the detection of WUCH, particularly in individuals with office grade 1 hypertension (AUC = 0.811, 95% CI = 0.793-0.829). The -1/-1 mmHg cutoff, which considers all individuals who had lower systolic or diastolic BP levels in the office than at home, had the highest AUC (0.822, 95% CI = 0.808-0.836) for the detection of MUCH. Both cutoff values also had the best performances for identifying all patients with higher and lower office-than-home BP grades. In conclusion, the 15/9 and -1/-1 mmHg cutoffs showed the best performance for the detection of treated hypertensive patients with WUCH and MUCH, respectively, and therefore might be markers of significant white-coat and masked effects and could be useful for identifying preferential targets for more routine home BP measures.421118161823CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ306154/2017-
Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use
Data on the association of blood pressure (BP) phenotypes with office and out-of-office markers of vascular stiffness and pressure wave reflection are sparse. This study investigated office and 24-h measures of brachial BP, pulse wave velocity (PWV), and central augmentation index (AIx) across hypertension phenotypes among individuals not using BP-lowering medications [normotension (NT), white-coat hypertension (WH), masked hypertension (MH) and sustained hypertension (SH)] and those using BP-lowering medications [controlled hypertension (CH), white-coat uncontrolled hypertension (WUCH), masked uncontrolled hypertension (MUCH) and sustained uncontrolled hypertension (SUCH)]. We evaluated 454 untreated (age = 45 +/- 15 years, 50% males) and 238 treated (age = 52 +/- 15 years, 45% males) individuals who underwent office and 24-h brachial BP, PWV, and AIx measures using a Mobil-O-Graph PWA monitor. In the analysis adjusted for age and sex, WH had higher (p < 0.05) office PWV (7.53 +/- 0.09 vs 6.89 +/- 0.05), office AIx (27.9 +/- 1.3 vs 23.8 +/- 0.8), and daytime AIx (24.6 +/- 0.7 vs 22.7 +/- 0.4) compared with those of NT, while WUCH had higher (p < 0.05) office PWV (8.28 +/- 0.11 vs 7.43 +/- 0.08) and 24-h PWV (7.54 +/- 0.09 vs 7.21 +/- 0.07) than those of CH. MH had higher (p < 0.05) 24-h PWV (7.00 +/- 0.09 vs 6.69 +/- 0.04) and 24-h AIx (24.3 +/- 0.9 vs 21.9 +/- 0.4) than those of NT, whereas MUCH had higher (p < 0.05) 24-h PWV (7.64 +/- 0.13 vs 7.21 +/- 0.07) than that of CH. Lastly, SH or SUCH had significantly higher office and 24-h PWV and AIx than those of NT and CH, respectively. In conclusion, these results suggest that individuals with masked BP phenotypes are more predisposed to have adverse out-of-office vascular characteristics, while individuals with white-coat phenotypes have adverse office and out-of-office vascular characteristics compared with those of individuals with normal BP levels.42121989199
Discrepancies in the diagnosis of hypertension in adolescents according to available office and home high blood pressure criteria
Abstract This study aimed at comparing the prevalence of abnormal blood pressure (BP) phenotypes among 241 adolescents referred for hypertension (15.4 ± 1.4 years, 62% males, 40% obese) according to mostly used or available criteria for hypertension [AAP or ESH criteria for high office BP (OBP); Arsakeion or Goiânia schools’ criteria for high home BP monitoring (HBPM)]. High OBP prevalence was greater when defined by AAP compared with ESH criteria (43.5% vs. 24.5%; p < .001), while high HBPM prevalence was similar between Arsakeion and Goiânia criteria (33.5% and 37.5%; p = .34). Fifty‐five percent of the sample fulfilled at least one criterion for high BP, but only 31% of this subsample accomplished all four criteria. Regardless of the HBPM criteria, AAP thresholds were associated with lower prevalence of normotension and masked hypertension and greater prevalence of white‐coat and sustained hypertension than ESH thresholds. These findings support the need to standardize the definition of hypertension among adolescents
Anuloplastia concêntrica do anel mitral, isolada ou associada à ressecção quadrangular, em crianças e jovens Mitral annuloplasty either in isolation or associated with posterior quadrantectomy in young patients
OBJETIVO: Descrever procedimento cirúrgico de anuloplastia concêntrica do anel mitral sem prótese, isolada ou associada à ressecção quadrangular com plicatura póstero-medial do anel mitral, e analisar os resultados imediatos e tardios obtidos. MÉTODO: Entre fevereiro de 1986 e fevereiro de 2001, realizamos 790 procedimentos abordando a valva mitral, 41 foram realizados em crianças e adolescentes menores de 20 anos (média de 9,7 anos). Vinte (48,7%) pacientes eram do sexo feminino e 21 (51,3%) do masculino. A doença reumática foi responsável pelas lesões em 92,6% dos casos e a degeneração mixomatosa em apenas 7,4%. No período pré-operatório, 22 (53,6%) pacientes estavam em classe funcional III e 19 (46,4%) em classe funcional IV, advindos de repetidos surtos de febre reumática, agravados pela desnutrição. A técnica cirúrgica utilizada foi a anuloplastia concêntrica, aplicada isoladamente ou em associação à ressecção quadrangular com plicatura póstero-medial. O curso do seguimento pós-operatório foi de 7 meses a 15 anos (3/2/1986 a 12/2/2001). RESULTADOS: A mortalidade hospitalar foi de 2,4%. Os pacientes receberam alta sem sopro sistólico de regurgitação mitral. Dois pacientes apresentaram, ao longo dos anos (4 e 11 anos), estenose mitral e necessitaram reoperação, um deles operado com dois anos de idade. Dois doentes foram reoperados para corrigir disfunção aórtica previamente abordada por plastia (12 e 18 meses após a primeira operação), morrendo e contribuindo para mortalidade tardia de 5%. CONCLUSÃO: Consideramos a técnica empregada um procedimento alternativo, válido, de aplicação preferencial em crianças e adolescentes, de fácil reprodução e de baixíssimo custo.OBJECTIVE: To describe the mitral anuloplasty technique either in isolation or associated with posterior quadrantectomy and to analyze the immediate and late results in young patients. METHOD: Between February 1986 and February 2001, 790 mitral valve procedures were performed in our Institution including 41 annuloplaties in patients with ages ranging from 1 to 20 years (Mean age = 9.7 years). 51.7% were males. The main etiologies were rheumatic disease (92.6%) and myxomatous degeneration (7.4%). Twenty-two (53.6%) patients were preoperatively in functional class III (NYHA), and 19 (46.4%) in class IV (NYHA), some in course of rheumatic fever aggravated by malnutrition. The technique employed was concentric mitral annuloplasty either in isolation or associated with posterior quadrantectomy. The follow-up ranged from 7 months to 15 years. RESULTS: The hospital mortality rate was 2.4%. All patients were discharged without mitral regurgitation. Two patients coursed with mitral stenosis (after 4 and 11 years respectively) and valve replacement was needed. Two patients coursed with aortic insufficiency (after 12 and 18 months) and died after aortic valve replacement, contributing to a 5% late mortality rate. CONCLUSION: In conclusion, mitral annuloplasty without ring either in isolation or associated with posterior quadrantectomy is a safe, easily reproducible especially in young patients